No attachments available.
FY26-27 Pediatric Covid-19 Vaccines
Contact and place of performance
Jariya Taylor
Atlanta, GA 30329
USA
https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=dce2e49762224496b03e8150d11fd0c8
The Centers for Disease Control and Prevention (CDC) issued this award notice for the procurement of pediatric COVID-19 vaccines for the 2026–2027 period. This award, identified by solicitation number 75D30126R73403, supports the agency’s ongoing vaccination efforts with a primary place of performance in Atlanta, Georgia. The notice was published and last updated on June 3, 2026, under the management of the contracting office's point of contact, Jariya Taylor.
The acquisition is classified under NAICS code 325412, which corresponds to Pharmaceutical Preparation Manufacturing. The associated Product Service Code (PSC) is 6505, covering Drugs and Biologicals. This award notice follows the federal procurement process for the supply of critical medical biologicals, though specific set-aside designations were not detailed in the metadata. No additional attachments or exhibits were included with this specific notice.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.